Literature DB >> 14673983

Catastrophic antiphospholipid syndrome: where do we stand?

Doruk Erkan1, Ricard Cervera, Ronald A Asherson.   

Abstract

Mesh：

Year:  2003        PMID： 14673983     DOI： 10.1002/art.11359

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  27 in total

Review 1.  Treatment of the antiphospholipid antibody syndrome.

Authors:  Christopher Wu; Kenneth Kalunian
Journal:  Curr Rheumatol Rep       Date:  2004-12       Impact factor: 4.592

2.  Long-term treatment of antiphospholipid syndrome-associated cerebral arterial thromboses with intravenous immunoglobulin: a case report.

Authors:  B Arabshahi; E D Thompson; E M Smergel; D P Goldsmith
Journal:  Clin Rheumatol       Date:  2005-12-03       Impact factor: 2.980

Review 3.  Clinical and laboratory features of the catastrophic antiphospholipid syndrome.

Authors:  Ljudmila Stojanovich; Dragomir Marisavljevic; Jozef Rovensky; Aleksandra Djokovich; Darina Kozáková; Nikola Milinic
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

4.  Catastrophic antiphospholipid syndrome triggered by sepsis.

Authors:  Susan Kim; Neal K Moskowitz; Edward F DiCarlo; Anne R Bass; Doruk Erkan; Michael D Lockshin
Journal:  HSS J       Date:  2008-12-19

5.  The catastrophic antiphospholipid syndrome in Serbia: diagnostic and management problems.

Authors:  Ljudmila Stojanovich
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

6.  Top 10 clinical research developments in antiphospholipid syndrome.

Authors:  Medha Barbhaiya; Doruk Erkan
Journal:  Curr Rheumatol Rep       Date:  2013-10       Impact factor: 4.592

7.  Catastrophic antiphospholipid antibody syndrome as a first manifestation of primary antiphospholipid antibody syndrome in a middle-aged man.

Authors:  Nazrul Hassan Jafry; Muhammed Mubarak; Ejaz Ahmed; Fazal Akhtar
Journal:  CEN Case Rep       Date:  2020-01-27

8.  Catastrophic antiphospholipid antibody syndrome following initiation of hemodialysis.

Authors:  Hideki Yotsueda; Kazuhiko Tsuruya; Masanori Tokumoto; Hideki Hirakata; Mitsuo Iida
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

Review 9.  Catastrophic antiphospholipid syndrome: treatment, prognosis, and the risk of relapse.

Authors:  Silvia Bucciarelli; Doruk Erkan; Gerard Espinosa; Ricard Cervera
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

Review 10.  Renal involvement in the antiphospholipid syndrome (APS)-APS nephropathy.

Authors:  Maria G Tektonidou
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.